Boron Neutron Capture Therapy for Malignant Meningiomas
The management of malignant meningioma (MM) is very difficult. In a large series of patients with this tumor, the MM recurrence rate was reported to be 78–84 % within 5 years, and the median survival of patients 6.89 years. Late mortality due to recurrence was to be 69 % after the initial surgery. Although some treatments for recurrent MM have been reported, a standard treatment has not yet been developed.
KeywordsNeutron Irradiation Gross Tumor Volume Boron Neutron Capture Therapy Local Tumor Progression Malignant Meningioma
- 8.Miyatake S, Kawabata S, Kajimoto Y et al (2005) Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimages. J Neurosurg 103:1000–1009PubMedCrossRefGoogle Scholar